Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Deficit (Unaudited)

v3.19.1
Consolidated Statement of Stockholders' Deficit (Unaudited) - USD ($)
Common Stock
Preferred Stock
Series A Convertible Preferred stock
Series B Convertible Preferred Stock
Series C Convertible Preferred Stock
Additional Paid-in Capital
Retained Earnings
Total
Equity Balance, Starting at Dec. 31, 2017 $ 5,457 $ 0 $ 0 $ 50 $ 50 $ 15,923,789 $ (22,237,839) $ (6,284,493)
Shares Outstanding, Starting at Dec. 31, 2017 54,564,441 0 0 500,000 500,000      
Common stock issued against common stock to be issued $ 0 $ 0 $ 0 $ 0 $ 0 15,000 0 0
Stock Issued During Period, Shares, New Issues 2,179 0 0 0 0      
Common shares issued in redemption of note $ 193 $ 0 $ 0 $ 0 $ 0 403,289 0 403,482
Common shares issued in redemption of note, shares 1,925,830 0 0 0 0      
Common stock issued for consulting services $ 17 $ 0 $ 0 $ 0 $ 0 817,783 0 817,800
Common stock issued for consulting services, shares 174,000 0 0 0 0      
Common stock to be issued for consulting services $ 0 $ 0 $ 0 $ 0 $ 0 0 0 9,500
Common stock to be issued for consulting services, shares 0 0 0 0 0      
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 (2,763,492) (2,763,492)
Shares Outstanding, Ending at Mar. 31, 2018 56,666,450 0 0 500,000 500,000      
Equity Balance, Ending at Mar. 31, 2018 $ 5,667 $ 0 $ 0 $ 50 $ 50 17,159,861 (25,001,331) (7,817,203)
Equity Balance, Starting at Dec. 31, 2018 $ 5,958 $ 0 $ 0 $ 50 $ 50 22,863,608 (28,992,485) (6,081,819)
Shares Outstanding, Starting at Dec. 31, 2018 59,582,890 0 0 500,000 500,000      
Common stock issued against common stock to be issued $ 0 $ 0 $ 0 $ 0 $ 0 0 0 7,500
Stock Issued During Period, Shares, New Issues 0 0 0 0 0      
Fair value of stock options $ 0 $ 0 $ 0 $ 0 $ 0 1,137,500 0 1,137,500
Stock Issued During Period, Value, Other $ 125 0 0 0 0 1,592,687 0 1,592,812
Stock Issued During Period, Shares, Other 1,250,000              
Common stock issued per stock purchase agreement $ 24 $ 0 $ 0 $ 0 $ 0 399,976 0 400,000
Common stock issued per stock purchase agreement, shares 239,521 0 0 0 0      
Net Income (Loss) $ 0 $ 0 $ 0 $ 0 $ 0 0 (2,342,677) (2,342,677)
Shares Outstanding, Ending at Mar. 31, 2019 61,072,411 0 0 500,000 500,000      
Equity Balance, Ending at Mar. 31, 2019 $ 6,107 $ 0 $ 0 $ 50 $ 50 $ 25,993,771 $ (31,335,162) $ (5,286,684)